-
81
Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma
Published 2023-06-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
82
736 Treatment with decitabine (DAC) induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer
Published 2021-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
83
1215 Using nanoparticles as artificial antigen presenting cells to activate human CD4 T cells for immunotherapy
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
84
Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer
Published 2022-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
85
329 Prolonged overall survival (OS) in patients with metastatic colorectal cancer (mCRC) in SPICE, a phase I study of enadenotucirev in combination with nivolumab
Published 2020-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
86
4 Combinations of immune checkpoint inhibitors with fractionated radiotherapy or DNA damage response agents leads to improved anti-tumour responses and modulates the tumour immune...
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
87
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
Published 2018-12-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
88
564 Single-cell transcriptomic analysis of immune compartments following combination immunotherapy treatment in poorly immunogenic tumors
Published 2021-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
89
Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
Published 2023-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
90
1254 Tumor-mediated education of bone marrow neutrophil progenitors facilitates the development of checkpoint inhibitor-associated toxicity
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
91
Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis
Published 2024-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
92
1296 Reconstructing gene expression from clinical and genetic panel data for predictions of tumor microenvironment features and response to immune checkpoint inhibitor therapy
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
93
349 A novel ‘off the shelf’ TCR-NK cell therapy platform for the treatment of solid tumours: development of optimised MAGE-A4 targeting TCR-NK cells for advancement into the clinic...
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
94
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors
Published 2021-04-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
95
Forecasting immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor t-cell therapy
Published 2022-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
96
Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma
Published 2021-08-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
97
966 Spatial profiling of the metastatic castration resistant prostate cancer tumor microenvironment at the single cell level reveals insights into intrinsic resistance to immunothe...
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
98
1232 PBMC humanized mouse model with clinical relevance in assessing the safety profile of 4–1BB agonist, urelumab, in 5 donors
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
99
Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic
Published 2018-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
100
124 Location, location, location: spatial analysis of ultrahigh-plex immunofluorescence panel in head and neck cancer
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article